Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Clinical Pharmacokinetics|October 20, 2022
Evaluation of Absorption and Metabolism-Based DDI Potential of Pexidartinib in Healthy SubjectsHamim Zahir, Jonathan Greenberg, Dale Shuster, et al.
Biopharmaceutics & Drug Disposition|September 23, 2022
Estimation of fraction of drug metabolism by a single UDP-glucuronosyl transferase enzyme using relative expression factorTomoyo Honda, Wataru Obuchi, Yumi Nishiya, et al.
BBA Advances|May 6, 2026
Collateral lethality of NAD kinase in 1p36 deleted tumors drives vulnerability to NAD kinase 2 depletionSaki Suyama-Banjo, Kengo Watanabe, Hirokazu Ishikawa, et al.
The Journal of Biological Chemistry|August 8, 2025
Proteasomal regulation of ASK family kinases dictates cell fate under hyperosmotic stressXiangyu Zhou, Kengo Watanabe, Kazuhiro Morishita, et al.
Clinical Pharmacology in Drug Development|November 12, 2022
Pharmacokinetics of the Multi-kinase Inhibitor Pexidartinib: Mass Balance and Dose ProportionalityHamim Zahir, Jonathan Greenberg, Ching Hsu, et al.
Drug Metabolism and Pharmacokinetics|October 10, 2020
Quantitative analysis of mRNA expression levels of aldo-keto reductase and short-chain dehydrogenase/reductase isoforms in human liversKeito Amai, Tatsuki Fukami, Hiroyuki Ichida, et al.
Geroscience|December 15, 2025
Discrimination of normal from slow-aging mice by plasma metabolomic and proteomic featuresBretton Badenoch, Oliver Fiehn, Noa Rappaport, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Discrimination of Normal from Slow-Aging Mice by Plasma Metabolomic and Proteomic FeaturesBretton Badenoch, Oliver Fiehn, Noa Rappaport, et al.
Pageof 6